MIST

Milestone Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↓ 4/10
  • Value↑ 5/10
Milestone Pharmaceuticals sales and earnings growth
MIST Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 14.10%
  • FCF Y/Y↓ -51.84%
Milestone Pharmaceuticals gross and profit margin trends
MIST Profitability
Neutral
  • Gross margin ↑ 99.20%
  • EPS margin↓ -3832.00%
  • ROIC 5Y↓ -55.27%
Milestone Pharmaceuticals net debt vs free cash flow
MIST Risk
Poor
  • Debt / Equity↑ 3.8
  • Debt / FCF↓ 1.3
  • Interest coverage↓ -8.7

Milestone Pharmaceuticals stock volatility is in-line with the overall market. We give it a Poor risk rating.

↗ More Biotechnology stocks